Introduction: the realities of antiretroviral therapy rollout: overcoming challenges to successful programmatic implementation

The Journal of Infectious Diseases
Bisola Ojikutu

Abstract

In 2006, 2 million human immunodeficiency virus (HIV)-infected people living in low- to middle-income countries were receiving antiretroviral therapy (ART). Although this is an improvement over previous years, significant operational challenges have inhibited progress toward universal access to HIV care and treatment. Despite these challenges, the intense efforts focused on addressing the HIV epidemic present an opportunity for overall health systems improvement in developing nations. In October 2006, Harvard University's Centers for AIDS Research, the Nelson Mandela School of Medicine, the Department of Health of KwaZulu-Natal, and the Medical Research Council of South Africa held a conference entitled "The Realities of Antiretroviral Therapy Rollout: Challenges to Successful Programmatic Implementation" in Durban, South Africa. The goal of the meeting was to bring together international and local leadership, including policy makers, health care workers, and funders, to propose an agenda that would address the challenges to more expeditious provision of HIV care and treatment in resource-limited settings.

References

Jan 3, 2008·AIDS·Sarah BernaysTony Barnett
Jan 10, 2008·The Journal of Infectious Diseases·Richard A MurphyRajesh T Gandhi
Jan 10, 2008·The Journal of Infectious Diseases·Pierre M BarkerDonald M Berwick
Jan 10, 2008·The Journal of Infectious Diseases·Martha BedeluHermann Reuter
Jan 10, 2008·The Journal of Infectious Diseases·Tammy MeyersGayle Sherman
Jan 10, 2008·The Journal of Infectious Diseases·Jason R AndrewsUNKNOWN Tugela Ferry Care and Research (TF CARES) Collaboration
Jan 10, 2008·The Journal of Infectious Diseases·Robin Wood
Jan 10, 2008·The Journal of Infectious Diseases·Aurora D KiviatRajesh T Gandhi
Jan 10, 2008·The Journal of Infectious Diseases·Lisa R HirschhornWilliam Rodriguez
Jan 10, 2008·The Journal of Infectious Diseases·Bisola OjikutuGita Ramjee

❮ Previous
Next ❯

Citations

Mar 5, 2013·Current HIV/AIDS Reports·Sten H Vermund, Richard J Hayes
Apr 3, 2008·The Journal of Clinical Investigation·Myron S CohenJoep Lange
Oct 20, 2009·BMC Infectious Diseases·Janneke H van DijkWilliam J Moss
Apr 2, 2010·Human Resources for Health·Mike CallaghanHelen Schneider
Mar 23, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Kristen UnderhillKen Mayer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
R E BarthH A Tempelman
International Journal of Epidemiology
Matthias EggerPaolo Miotti
© 2021 Meta ULC. All rights reserved